Related stories
‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
How not to revive Europe’s auto industry
Who should pay for a birthday dinner? I always treat my guests.
White House asks US envoy to Greece Kimberly Guilfoyle to resign
Why one hedge-fund billionaire believes stocks are heading for a ‘really challenging’ 2027
This one move will save $20,000 on our wedding